Home
Sinapi Biomedical

Sinapi Biomedical Market Share Analysis for May 2026

Industry: N/A

Domainsinapibiomedical.com

Year Founded2006

Employees51 - 200

Annual Revenue$15M - $25M

Sinapi Biomedical

Sinapi Biomedical (including company regionals)

sinapibiomedical.com

See more website traffic and engagement information

Sinapi Biomedical Revenue up to May 2026 is 15M - 25M

revenue generated by Sinapi Biomedical top domains

Sinapi Biomedical top domains revenue over 3 years

Revenue for Sinapi Biomedical top domains

sinapibiomedical.com15M - 25M

See more with Sales Intelligence

Total visits to Sinapi Biomedical's top domains

Understand Sinapi Biomedical market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

sinapibiomedical.com664

See more with Sales Intelligence

Avg. visit duration in Sinapi Biomedical's top domains

Analyze Sinapi Biomedical engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

sinapibiomedical.com--

See more with Sales Intelligence

Avg. pageviews on Sinapi Biomedical's top domains

See how Sinapi Biomedical keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

sinapibiomedical.com1.03

See more with Sales Intelligence

Sinapi Biomedical top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Sinapi Biomedical

These are the website technologies, by industry, used by Sinapi Biomedical top domains

Widget (7)

Twemoji

Content Management System (2)

WordPress

Mobile (2)

Meta Viewport

Advertising (1)

DoubleClick

More Technologies

6

See all

News & Signals from Sinapi Biomedical

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsSinapi Biomedical launched Ellavi uterine balloon tamponade on Jun 3rd '19.PATH and Sinapi Biomedical announced today at the Women Deliver 2019 Conference that the Ellavi uterine balloon tamponade (UBT) has achieved CE marking, signifying that the medical device meets European regulatory requirements.